Amrutanjan Healthcare

BSE : 590006 | NSE : AMRUTANJAN
Industry : Pharma Formulations | ISIN : INE098F01031 | FreeFloat : 26.16% | FnO : No | LotSize : N/A
Intellectual Capital (IC)498.55
Net Worth (NW)272.98
Intrinsic Worth (IW)771.53
Market Cap (MC)2,089.41
Economic Value Added2.35
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)64.62%
IC Gross Margin (EBITDA/IC)16.94%
IC Net Margin (NPT/IC)11.42%
Knowledge Turnover (Sales/IC)0.87
Market to Intrinsic Value (MC/IW)2.71
As OfIntrinsic ValueMarket Price
30 Sep 2022Rs. 263.95Rs. 714.80
3 Feb 2023 ---- Rs. 709.10
-9.90     -1.40%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : YesBuy10 DMA : Rs. 713.41SellAvoid
KB > 50% : Yes50 DMA : Rs. 710.98
0 < M2IV < 1 : NoVol-Price trend : Falling
Disclaimer: Stock outlook is based on data calculations only and does NOT constitute investment advice.

Question 3 - Is this stock undervalued?

Question 2 - Does this business have significant knowledge assets?

Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.
Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Dec-19
S
82.75
85.01
11.60
12.65
12.60
9.49
9.49
Mar-20
S
59.32
61.96
11.73
10.71
10.64
7.89
7.89
Jun-20
S
46.62
48.66
9.65
8.71
8.66
6.43
6.40
Sep-20
S
92.11
96.16
32.32
31.43
31.39
23.55
23.72
Dec-20
S
100.10
102.64
29.03
28.19
28.14
20.99
20.77
Mar-21
S
94.02
96.70
15.07
14.08
13.71
10.23
10.28
Jun-21
S
78.21
80.95
17.29
16.37
16.29
12.06
12.03
Sep-21
S
110.38
114.67
27.23
26.43
26.36
19.85
19.45
Dec-21
S
110.70
113.89
28.82
27.94
27.92
20.58
20.34
Mar-22
S
106.55
111.71
21.51
20.32
20.02
14.71
14.71
Jun-22
S
70.95
73.97
6.34
5.27
5.25
3.66
3.66
Sep-22
S
110.72
113.75
18.96
17.44
17.42
12.77
12.77
* C - Consolidated, S - Standalone